Agents for dyeing keratin fibres, containing at least one dimeric, dicationic azo dye with special substitution pattern

US10406089B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10406089-B2
Application numberUS-201515528529-A
CountryUS
Kind codeB2
Filing dateOct 14, 2015
Priority dateNov 25, 2014
Publication dateSep 10, 2019
Grant dateSep 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure relates to agents for dyeing keratin fibers, in particular human hair, containing, in a cosmetic carrier (a) at least one direct dye of formula (I), wherein Het1, Het2 represent cationic heterocycles; R1, R3 respectively represent a substitute which is not hydrogen, and Q represents a grouping of formula (VIII), (IX), or (X).

First claim

Opening claim text (preview).

The invention claimed is: 1. An agent for changing the colour of keratinic fibers, the agent comprising, in a cosmetic support, (a) at least one direct dye with formula (I), wherein one of Het1 and Het2 represents one of the structures (II), (III), (IV), (V), (VI) or (VII), and the other of Het1 and Het2 represents one of the structures (III), (V), (VI) or (VII), R1, R3 independently of each other represent a C 1 -C 6 alkyl group or a C 1 -C 6 alkoxy group, R2, R4 each represent a hydrogen atom, R5, R6 independently of each other represent a hydrogen atom, a C 1 -C 6 alkyl group or a C 2 -C 6 alkenyl group, Q represents a group with formula (VIII), * —(CH 2 )n-*  (VIII) n represents a whole number from 3 to 6, R7, R10 each independently of each other represent a C 1 -C 6 alkyl group or a C 2 -C 6 alkenyl group, R8, R9 each independently of each other represent a hydrogen atom, a C 1 -C 6 alkyl group, a halogen atom from the group chlorine, bromine, fluorine or iodine, a C 1 -C 6 alkoxy group or a nitro group, and X represents a physiologically acceptable anion selected from the group consisting of chloride, bromide, iodide, methyl sulphate, methyl sulphonate, p-toluenesulphonate, acetate, hydrogen sulphate, ½ sulphate or ½ tetrachlorozincate. 2. The agent as claimed in claim 1 , wherein the agent comprises (a) at least one direct dye with general formula (I), in which Het1, Het2 independently of each other respectively represent one of the structures (II), (III) or (IV): 3. The agent as claimed in claim 1 , wherein the agent comprises (a) at least one direct dye with general formula (I), in which R5, R6 independently of each other represent hydrogen or a C 1 -C 6 alkyl group. 4. The agent as claimed in claim 1 , wherein the agent comprises (a) at least one direct dye with general formula (I), in which R7, R10 each independently of each other represent a methyl group or an ethyl group, R8, R9 represents a hydrogen atom. 5. The agent as claimed in claim 1 , wherein the agent comprises at least one direct dye with general formula (I) which is selected from: 3-methyl-2-[2-(3-methyl-4-{[3-({2-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)propyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-[2-(2-methyl-4-{[3-({3-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)propyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-[2-(3-methyl-4-{[4-({2-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)butyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-[2-(2-methyl-4-{[4-({3-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)butyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-[2-(3-methyl-4-{[5-({2-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)pentyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-[2-(2-methyl-4-{[5-({3-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)pentyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-(2-{3-methyl-4-[methyl({3-[methyl({2-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)propyl]amino}phenyl)diazen-1-yl]-1,3-thiazol-3-ium salts, 3-methyl-2-(2-{3-methyl-4-[ethyl({3-[ethyl({2-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl })amino]propyl })amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 3-methyl-2-(2-{2-methyl-4-[methyl({3[methyl({3-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl })amino]propyl })amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 3-methyl-2-(2-{2-methyl-4-[ethyl({3-[ethyl({3-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl })amino]propyl })amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 3-methyl-2-(2-{3-methyl-4-[methyl({4-[methyl({2-methyl-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl)}amino]butyl })amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 3-methyl-2-(2-{2-methyl-4-[methyl({4-[methyl({3-methyl-4-[2-(3-methyl-1,3 -thiazol-3-ium-2-yl)diazen-1-yl]phenyl})amino]butyl})amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 3-methyl-2-(2-{3-methyl-4-[methyl({5-[methyl({2-methyl-4-[2-(3-methyl-1,3 -thiazol-3-ium-2-yl)diazen-1-yl]phenyl})amino]pentyl})amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 3-methyl-2-(2-{2-methyl-4-[methyl({5-[methyl({3-methyl-4-[2-(3-methyl-1,3 -thiazol-3-ium-2-yl)diazen-1-yl]phenyl})amino]pentyl})amino]phenyl}diazen-1-yl)-1,3 -thiazol-3-ium salts, 2-[2-(3-methoxy-4-{[3-({2-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)propyl]amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(2-methoxy-4-{[3-({3-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)propyl]amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(3-methoxy-4-{[4-({2-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)butyl]amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(2-methoxy-4-{[4-({3-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)butyl]amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(3-methoxy-4-{[5-({2-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)pentyl]amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(2-methoxy-4-{[5-({3-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}amino)pentyl]amino }phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(3-methoxy-4-{[3-({2-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl}(methyl)amino)propyl](methyl)amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(2-methoxy-4-{[3-({3-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl }(methyl)amino)propyl](methyl)amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(3-methoxy-4-{[4-({2-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl }(methyl)amino)butyl]methyl)amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(2-methoxy-4-{[4-({3-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl }(methyl)amino)butyl]methyl)amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(3-methoxy-4-{[5-({2-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl }(methyl)amino)pentyl]methyl)amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 2-[2-(2-methoxy-4-{[5-({3-methoxy-4-[2-(3-methyl-1,3-thiazol-3-ium-2-yl)diazen-1-yl]phenyl }(methyl)amino)pentyl]methyl)amino}phenyl)diazen-1-yl]-3-methyl-1,3-thiazol-3-ium salts, 5-[2-(4-{[3-({4-[2-(1,4-dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]-2-methylphenyl }amino)propyl]amino}-3-methylphenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium salts, 5-[2-(4-{[3-({4-[2-(1,4-dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]-3-methylphenyl }amino)propyl]amino}-2-methylphenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium salts, 5-[2-(4-{[4-({4-[2-(1,4-dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]-2-methylphenyl }amino)butyl]amino}-3-methylphenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium salts, 5-[2-(4-{[4-({4-[2-(1,4-dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]-3-methylphenyl }amino)butyl]amino}-2-methylphenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium salts, 5-[2-(4-{[5-({4-[2-(1,4-dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]-2-methylphenyl }amino)pentyl]amino}-3-methylphenyl)dia

Assignees

Inventors

Classifications

  • Thiazoles or hydrogenated thiazoles · CPC title

  • having three nitrogen atoms as the only ring hetero atoms · CPC title

  • 1,3-Diazoles or hydrogenated 1,3-diazoles {; (Benz)imidazolium} · CPC title

  • 1,2-Diazoles or hydrogenated 1,2-diazoles {; Pyrazolium; Indazolium} · CPC title

  • in preparations for temporarily coloring the hair further containing an oxidizing agent · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10406089B2 cover?
The disclosure relates to agents for dyeing keratin fibers, in particular human hair, containing, in a cosmetic carrier (a) at least one direct dye of formula (I), wherein Het1, Het2 represent cationic heterocycles; R1, R3 respectively represent a substitute which is not hydrogen, and Q represents a grouping of formula (VIII), (IX), or (X).
Who is the assignee on this patent?
Henkel Ag & Co Kgaa
What technology area does this patent fall under?
Primary CPC classification A61K8/49. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).